Bank of Montreal’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $212M | Sell |
4,042,863
-596,936
| -13% | -$31.6M | 0.07% | 226 |
|
|
2026
Q1 | $256M | Buy |
4,639,799
+2,039,895
| +78% | +$111M | 0.1% | 176 |
|
|
2025
Q4 | $127M | Sell |
2,599,904
-251,799
| -9% | -$11.7M | 0.04% | 321 |
|
|
2025
Q3 | $123M | Buy |
2,851,703
+465,916
| +20% | +$18.2M | 0.05% | 280 |
|
|
2025
Q2 | $91.6M | Buy |
2,385,787
+2,062,996
| +639% | +$78.8M | 0.04% | 284 |
|
|
2025
Q1 | $12.5M | Buy |
322,791
+7,076
| +2% | +$259K | 0.01% | 864 |
|
|
2024
Q4 | $10.7M | Sell |
315,715
-4,524
| -1% | -$163K | 0.01% | 972 |
|
|
2024
Q3 | $13M | Sell |
320,239
-10,413
| -3% | -$426K | 0.01% | 936 |
|
|
2024
Q2 | $13.4M | Sell |
330,652
-10,713
| -3% | -$451K | ﹤0.01% | 903 |
|
|
2024
Q1 | $14.7M | Buy |
341,365
+4,787
| +1% | +$197K | ﹤0.01% | 840 |
|
|
2023
Q4 | $12.5M | Sell |
336,578
-17,308
| -5% | -$621K | ﹤0.01% | 952 |
|
|
2023
Q3 | $13.3M | Buy |
353,886
+345,409
| +4,075% | +$12.3M | ﹤0.01% | 873 |
|
|
2023
Q2 | $302K | Sell |
8,477
-1,138
| -12% | -$40.8K | ﹤0.01% | 2943 |
|
|
2023
Q1 | $342K | Sell |
9,615
-1,043
| -10% | -$36.5K | ﹤0.01% | 2697 |
|
|
2022
Q4 | $375K | Buy |
10,658
+2,006
| +23% | +$66.8K | ﹤0.01% | 2778 |
|
|
2022
Q3 | $255 | Sell |
8,652
-417,596
| -98% | -$15.8M | ﹤0.01% | 3043 |
|
|
2022
Q2 | $23.3K | Sell |
426,248
-145,574
| -25% | -$8.04M | 0.01% | 692 |
|
|
2022
Q1 | $31.2M | Buy |
571,822
+121,133
| +27% | +$6.58M | 0.02% | 626 |
|
|
2021
Q4 | $24.9M | Sell |
450,689
-2,240
| -0.5% | -$117K | 0.01% | 667 |
|
|
2021
Q3 | $21.7M | Buy |
452,929
+24,857
| +6% | +$1.25M | 0.01% | 893 |
|
|
2021
Q2 | $21.4M | Buy |
428,072
+257,298
| +151% | +$12.4M | 0.01% | 870 |
|
|
2021
Q1 | $7.78M | Buy |
170,774
+63,413
| +59% | +$2.88M | 0.01% | 1138 |
|
|
2020
Q4 | $5.09M | Buy |
107,361
+8,131
| +8% | +$373K | ﹤0.01% | 1374 |
|
|
2020
Q3 | $4.57M | Sell |
99,230
-7,826
| -7% | -$392K | ﹤0.01% | 1249 |
|
|
2020
Q2 | $5.4M | Buy |
107,056
+29,005
| +37% | +$1.49M | ﹤0.01% | 1133 |
|
|
2020
Q1 | $3.68M | Sell |
78,051
-107,997
| -58% | -$5.76M | ﹤0.01% | 1133 |
|
|
2019
Q4 | $10.9M | Sell |
186,048
-6,661
| -3% | -$371K | 0.01% | 934 |
|
|
2019
Q3 | $10.3M | Buy |
192,709
+52,455
| +37% | +$2.7M | 0.01% | 870 |
|
|
2019
Q2 | $7.02M | Sell |
140,254
-8,372
| -6% | -$420K | 0.01% | 1054 |
|
|
2019
Q1 | $7.76M | Buy |
148,626
+51,150
| +52% | +$2.56M | 0.01% | 949 |
|
|
2018
Q4 | $4.66M | Sell |
97,476
-10,799
| -10% | -$532K | ﹤0.01% | 1101 |
|
|
2018
Q3 | $5.44M | Buy |
108,275
+2,048
| +2% | +$104K | ﹤0.01% | 1145 |
|
|
2018
Q2 | $5.35M | Sell |
106,227
-3,245
| -3% | -$163K | ﹤0.01% | 1141 |
|
|
2018
Q1 | $5.35M | Buy |
109,472
+5,121
| +5% | +$238K | ﹤0.01% | 1117 |
|
|
2017
Q4 | $4.63M | Sell |
104,351
-118,715
| -53% | -$5.48M | ﹤0.01% | 1163 |
|
|
2017
Q3 | $11.3M | Buy |
223,066
+100,506
| +82% | +$5.1M | 0.01% | 807 |
|
|
2017
Q2 | $6.61M | Buy |
122,560
+19,970
| +19% | +$1.06M | 0.01% | 1033 |
|
|
2017
Q1 | $5.41M | Buy |
102,590
+8,329
| +9% | +$423K | 0.01% | 1035 |
|
|
2016
Q4 | $4.45M | Buy |
94,261
+1,356
| +1% | +$67K | ﹤0.01% | 1143 |
|
|
2016
Q3 | $5.01M | Sell |
92,905
-709
| -0.8% | -$38.9K | 0.01% | 1099 |
|
|
2016
Q2 | $5.07M | Buy |
93,614
+15,684
| +20% | +$826K | 0.01% | 1099 |
|
|
2016
Q1 | $3.95M | Buy |
77,930
+4,875
| +7% | +$243K | ﹤0.01% | 1126 |
|
|
2015
Q4 | $3.69M | Sell |
73,055
-7,925
| -10% | -$404K | ﹤0.01% | 1111 |
|
|
2015
Q3 | $3.89M | Buy |
80,980
+16,754
| +26% | +$872K | 0.01% | 1040 |
|
|
2015
Q2 | $3.34M | Buy |
64,226
+3,233
| +5% | +$182K | ﹤0.01% | 1193 |
|
|
2015
Q1 | $3.52M | Sell |
60,993
-3,561
| -6% | -$204K | ﹤0.01% | 1156 |
|
|
2014
Q4 | $3.45M | Sell |
64,554
-5,138
| -7% | -$287K | ﹤0.01% | 1183 |
|
|
2014
Q3 | $4.01M | Sell |
69,692
-25,818
| -27% | -$1.58M | ﹤0.01% | 1172 |
|
|
2014
Q2 | $6.38M | Sell |
95,510
-19,721
| -17% | -$1.33M | 0.01% | 1002 |
|
|
2014
Q1 | $7.7M | Buy |
115,231
+20,347
| +21% | +$1.38M | 0.01% | 768 |
|
|
2013
Q4 | $6.33M | Sell |
94,884
-421
| -0.4% | -$27.3K | 0.01% | 756 |
|
|
2013
Q3 | $5.98M | Sell |
95,305
-30,241
| -24% | -$1.95M | 0.01% | 715 |
|
|
2013
Q2 | $7.84M | Buy |
+125,546
| New | +$7.97M | 0.01% | 576 |
|
Other funds holding GSK
JEST
MIP
Bank of Montreal's GSK Position: Q2 2026 in Review
Bank of Montreal reduced its GSK (GSK) stake by 13% in Q2 2026, selling an estimated $31.6M and leaving 4,042,863 shares worth $212M. The position accounts for 0.07% of the portfolio, ranked #226.
Bank of Montreal first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $256M in Q1 2026. 935 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Bank of Montreal held 4,042,863 shares of GSK worth $212M as of Q2 2026.
- Bank of Montreal sold 596,936 GSK shares in Q2 2026, an estimated $31.6M.
- GSK made up 0.07% of Bank of Montreal's portfolio in Q2 2026, its #226 holding.
- Bank of Montreal first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
- Bank of Montreal's GSK position peaked at $256M in Q1 2026.
- 935 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.